SOL Global Archives - Green Market Report

StaffOctober 26, 2023


The Daily Hit is a recap of the top financial news stories for Oct. 26, 2023.

On the Site

Cannabis Operators Sue US Over the CSA, Intrastate Commerce

A coalition of U.S. cannabis operators and investors, including some of the largest multistate operators, filed a lawsuit against U.S. Attorney General Merrick Garland, alleging that the federal government has no basis for enforcing the Controlled Substances Act against intrastate, state-regulated cannabis operations. Read more here.

Humble & Fume Sales Tick Up in FY2023

North American cannabis distributor Humble & Fume Inc. (CSE: HMBL) (OTC Pink: HUMBF) reported total revenue of C$68.5 million for the fiscal year ended June 30, a year-over-year increase of 3.6%. Most of that growth was attributed to the company’s California distribution business. U.S. revenue for the year totaled C$40 million, up 5% over the previous year. Read more here.

SOL Global Trims Losses in Third Quarter

SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) announced unaudited financial results for the third quarter ending August 31, 2023 in Canadian dollars. Sol Global recorded a net loss of ($6.9) million vs. last year’s net loss of ($12.5) million for the same period. This was an improvement of $5.6 million. Read more here.

Report: Blanket Federal Legalization Could Upend State Markets

While much of the cannabis industry has its sights set on federal legalization of cannabis, not everyone is as excited about the tone that many of the conversations have taken. A new report from the Parabola Center warns of the emergence of a U.S. marijuana monopoly if the federal government legalizes the drug. Read more here.

In Other News


Nebraska’s attorney general on Wednesday announced a major crackdown on retailers hawking hemp-derived products containing intoxicating cannabinoids, which he said were dangerous for human consumption. Read more here.


Labstat, a provider of tobacco/nicotine and cannabis/hemp testing and research services, has opened a new laboratory in Utrecht, The Netherlands. Read more here.

University at Buffalo

A University at Buffalo psychologist has received a $3.2 million grant from the National Cancer Institute to assess how cannabis use affects patients who receive immunotherapy, a rapidly advancing treatment that helps the immune system fight cancer. Read more here.

StaffJuly 10, 2023


The Daily Hit is a recap of the top financial news stories for July 10, 2023.

On the Site

Chicago Atlantic Talks New York’s $150 Million Equity Investment Deal

Chicago Atlantic stepped in with a pledge of up to $150 million to the social equity fund for building out New York dispensaries via small business loans. Managing director Peter Sack spoke with Green Market Report to fill in some of the details on how the investment deal came about. Read more here.

SEC Orders Sol Global Founder Andy DeFrancesco to Pay Millions in Stock Fraud Case

On July 5, the U.S. District Court for the Southern District of New York entered a final judgment on consent against Andrew DeFrancesco, the former chairman of Cool Holdings Inc., for his role in a scheme involving false statements and omissions of material information in filings with the commission, as well as a fraudulent pump-and-dump of Cool Holdings’ stock. Read more here.

Report: Virginia Governor ‘Not Interested’ in Adult-Use Cannabis Market

Both Virginia’s marijuana and hemp markets are in serious disarray, thanks to regulatory uncertainty handed down by the state’s Republican leadership. Now the previously expected launch of recreational marijuana sales in January 2024 is in more serious doubt than ever. Read more here.

Arkansas, Connecticut Cannabis Sales Continue Setting Records

Both Arkansas and Connecticut continued their respective marijuana sales tears in 2023 by setting sales records in June. At the same time, Michigan saw market prices stabilize after record lows in February. Read more here.

Illinois Cannabis Sales Turn Around in June

Monthly marijuana sales in Illinois reached their highest level so far this year in June, increasing 8% year-over-year and shaking off several months of sluggish performance. Read more here.

In Other News


Recreational and medical marijuana sales numbers released in June by the Colorado Department of Revenue showed the lowest marijuana sales in the month of April since 2018. Numbers showed $131 million in marijuana sales for April 2023, the most recent data, down from more than $153 million in sales in April of 2022. Marijuana sales in the month of April haven’t been this low since 2018. Read more here.


Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) unveiled the strategic national rebrand of its Select cannabis lifestyle brand across 15 U.S. states. Read more here.

InterCure Ltd.

InterCure Ltd. (Nasdaq: INCR) (TSX: INCR.U) (TASE: INCR), dba Canndoc, announced that its board of directors approved the voluntarily delisting of the company’s common shares from the Toronto Stock Exchange. The Company has decided to delist from the TSX after concluding that maintaining the listing does not offer substantial benefits to the company and its shareholders. Read more here.

Debra BorchardtNovember 1, 2022


SOL Global Investments Corp. (CSE: SOL) (OTCPK: SOLCF) provided its investors with unaudited financials for the third quarter ending Aug. 31, 2022, as the company shifts away from cannabis. Sol Global did not release any revenue figures but instead noted its net losses.

For the third quarter, the total loss from investments was $11.2 million versus a gain of $12.5 million for the same period in 2021. This represents an unfavorable change of ($23.7) million between periods. The net loss for the quarter was $12.5 million, an improvement over last year’s net loss of $62.4 million.

Total loss from investments for the last nine months was $190.7 million, versus a gain of $341 million for the same period in 2021. This represents an unfavorable change of ($531.7) million between periods.

The company has reduced its stake in cannabis from 18% to 14% and is instead gravitating to companies like electric motorcycle company Damon Motors and robotic delivery company Kiwi Campus.

“SOL’s solid portfolio foundation continues to show resilience despite market volatility,” stated Kevin Taylor, SOL Global’s chairman and CEO. “We continue to monitor market headwinds as we oversee and adjust our portfolio to maximize returns.”

The company noted that its net asset value has fallen from last year’s third-quarter price of $6.44 to $3.08. In addition, Sol Global stated that it has a new debt of $10 million, a nonrevolving loan term facility of $11 million, and other liabilities of $25 million.

Cannabis Updates

  • Common C Holdings LP, a Michigan-based vertically integrated cannabis company and lifestyle brand, recently launched a cultivation partnership with boxing legend Mike Tyson’s premium cannabis line, California-based Tyson 2.0 (in which the company also holds a minority stake). Common Citizen will grow Tyson’s cannabis at its state-of-the-art hybrid greenhouse in Michigan and will first yield “Knockout OG” and “Pound for Pound Cake”- both favorite strains of Tyson’s. The cannabis will be sold at Common Citizen retail partners in prepackaged eighths (3.5 grams) and 1-gram pre-rolls.
  • The company has an interest in Fyllo, which in June 2022 announced its expansion into the cryptocurrency vertical.
  • SOL has an interest in Jones Soda, which it said experienced strong growth across all major sales channels for its core bottled soda business and subsequently launched its Mary Jones cannabis-infused soda line, with 10 milligram cannabis-infused sodas, now available in Jones’ fan-favorite root beer, berry lemonade, green apple, and orange & cream flavors in the California market.

Debra BorchardtOctober 29, 2021


SOL Global Investments Corp.  (CSE: SOL) (OTCPK: SOLCF) reported an unaudited earnings result for the quarter ending August 31, 2021, with a loss of $62.4 million versus last year’s income of $43.7 million for the same time period. Sol Global noted that this was a negative change of $106.1 million. The company attributed it to the one-time expense related to the settlement agreement with its former lender of $68.5 million.

For the quarter the company only reported $12.5 million in total gains from investments versus last year’s $60.3 million for the same time period. This represents a negative change of $47.8 million between periods. Sol Global claims this is due to an overall weakness in the market.

“Managing small cap and cannabis investments from the long side during third quarter was like playing tag in a minefield,” said Andy DeFrancesco, SOL Global’s Chairman and CEO. “Even positive news saw stock prices continue to drop. Once again my team battled through and we outperformed in our sectors. We remain extremely confident in our underlying holdings and will not transact from the pressures of short-term price fluctuations. We will stick to our 2 to 5 year time horizons on core positions which allow for smaller companies to properly execute on the business models we are backing.”

Loan Settlement Woes

Sol Global settled its litigation with its previous lender 1235 Fund. The two companies engaged in a battle over whether the once private Verano shares could be claimed as collateral for a loan. Sol Global tried to get the case moved to New York but was rebuffed. 1235 Fund had actually suggested that the shares were worth $500 million but ultimately settled for less.

In August it was announced that a subsidiary of SOL Global would buy all of 1235’s rights under the Debenture for C$120 million (which was C$68.5 million above the Debenture’s principal and accrued interest) and that was paid on September 7, 2021. The subsidiary got an equity investment from SOL Global which has entered into a loan agreement with an arm’s length private lender for a secured loan in the principal amount of C$50 million. The Loan will have a term of 12 months and will bear interest at the rate of 9% per annum.

The conflict between the two parties arose after Sol Global began claiming that MMCap and 1235 Fund had no rights to the Verano shares as repayment for a loan. Sol Global was in a cash crunch back in July 2019. The one thing of potential value it owned was a large investment in the privately-held cannabis company Verano. MMCap bought the debenture through what was called the 1235 Fund giving Sol $50 million with the risk that Sol could possibly go under and not repay the $50 million or the Verano shares could end up being worth much less than the $50 million it had spent. At the time, it was a risky deal as it was difficult to determine the outcome. Cannabis stocks were suffering through a tremendous bear market and valuations had plunged across the board. Sol Global wanted to just pay back 1235 Fund in cash, while 1235 Fund wanted to take the now publicly-traded  Verano shares as repayment.

Debra BorchardtJune 7, 2021


Cannabis Law Reports reported that Sol Global (OTC: SOLCF) lost the first round in its lawsuit with investor MMCap. Sol Global had filed a case in the state of New York regarding the repayment of a $50 million loan. At the heart of the lawsuit is a big chunk of Verano shares, which MMCap and the 1235 Fund say belong to them as an option for the repayment of the loan, while Sol Global claims the shares belong to them alone and that all the 1235 Fund gets is a cash repayment.

Judge Jennifer Schecter wrote that of all interested parties only one, Verano Blocker 2, specifically agreed to New York as a place of jurisdiction. She also described the group as “sophisticated parties” suggesting all the parties understood what had been agreed to for jurisdiction. MMCap and the 1235 Fund filed their case in Ontario, which Judge Schechter said was consistent in the other clauses in the agreements signed by the parties.

“In the end, defendants never consented to personal jurisdiction in New York or waived the objection; thus, this action is dismissed. Moreover, jurisdictional discovery is unwarranted because the complaint does not make a sufficient start at suggesting there could even possibly be a basis for New York jurisdiction,” wrote the Judge in her two-page decision.

Sol Global did not respond to a request for comment.

Sol Global & The 1235 Fund History

The conflict between the two parties arose after Sol Global began claiming that MMCap and 1235 Fund had no rights to the Verano shares as repayment for a loan. Sol Global was in a cash crunch back in July 2019. The one thing of potential value it owned was a large investment in the privately-held cannabis company Verano. MMCap bought the debenture through what was called the 1235 Fund giving Sol $50 million with the risk that Sol could possibly go under and not repay the $50 million or the Verano shares could end up being worth much less than the $50 million it had spent. At the time, it was a risky deal as it was difficult to determine the outcome. Cannabis stocks were suffering through a tremendous bear market and valuations had plunged across the board.

At one time, Harvest Health & Recreation (HRVSF) had said it was going to acquire Verano in a deal valued at $850 million, but then the deal unraveled. Both parties agreed to terminate it and walk away. This is where the disagreement begins between Sol and MMCap. Sol claims that once the Harvest deal was over, that MMCap had no options to receive the stock as payment, and that MMCap could only get a cash payment.

MMCap says that isn’t true and even includes in its lawsuit the language from the debenture document that seems to support its claim to having an equity option. The debenture language according to MMCap says that if the Harvest deal didn’t happen, MMCap would receive 1,730,794 shares of Verano. MMCap says that the termination of the Harvest deal actually had the opposite effect to what Sol claims. Instead of getting paid in cash, the debenture language says that the termination of the deal meant MMCap would have to accept the Verano shares as payment. At that time, Sol would have been able to walk away from the $50 million debenture by only having to turn over the shares which looked to be worth far less than they are today. MMCap also says in its lawsuit that Sol wasn’t paying its interest payments on time and could only pay what it owed in tranches.

According to a court document filed in Canada, MMCap wants its repayment in the form of those Verano shares. It is insisting that it has the option to request payment in shares, which could be worth as much as $500 million. MMCap was supposedly trying to resolve the matter between the parties, but during those discussions, Sol Global filed this lawsuit in New York saying that MMCap did not have the option to choose Verano shares as a form of repayment and that it would instead pay the debenture amount in cash. Now that Sol Global has lost this initial round, it looks like the case conflict will remain in Canada.

StaffApril 29, 2021


SOL Global Investments Corp.  (OTCPK: SOLCF) provided its investors with unaudited financials for the first quarter ended February 28, 2021, and a general operational update concerning its assets and investments. Sol Global recorded a positive net income of $208 million versus quarter-end February 29, 2020, of $2.9 million. The increase was due to the company selling Bluma Wellness to Cresco Labs Inc. in an all-stock transaction valued at $213 million. As of February 28, 2021, the company had $18 million in cash.

“I’m pumped for our stockholders and beyond proud of my team and partners for today’s results,” said SOL Global’s Chairman and CEO, Andy DeFrancesco. “Our year end results were strong, but we shattered expectations with this most recent quarter. Going forward, our sectors and holdings may change but our strategy, risk management and dedication to our stockholders will not.”

Verano Update

Sol Global has been tied up in a legal dispute over its ownership of Verano shares. The dispute is regarding the repayment of the debenture Sol Global sold to MMCap in July 2019 through what’s called the 1235 Fund. According to the court documents filed in Canada, MMCap wants its repayment in the form of those Verano shares. It is insisting that it has the option to request payment in shares, which could be worth as much as $500 million. Sol Global preemptively filed a lawsuit in New York saying that MMCap did not have the option to choose Verano shares as a form of repayment and that it would instead accept payment of the debenture amount in cash.

Sol Global’s update was that the company would be asking to stay the Ontario claim on the basis that the issues are already before the New York courts. It should be noted that MMCap filed its lawsuit on February 25, 2021 and Sol Global has yet formally file the request to stay the Ontario claim.  The lender has asked that the proceedings in New York be stayed or dismissed, arguing that these matters should be decided by a court in Ontario.

Investors should be aware that if the court awards the shares to MMCap that would certainly negatively affect Sol Global. Sol Global continues to tout the accomplishments of Verano in the hopes the shares get awarded to Sol Global and thus increase its own valuation. Sol Global also said in its filings that no amounts have been reserved in the financial statements of the company with respect to the Ontario Claim.

Other Investments

Sol Global outlined the company’s other investments as follows:

  • Its intention to increase its ownership interest in Captor Capital (the parent company of One Plant California) to 15.7%.
  • The company co-led Fyllo’s $30 million dollar Series B Financing, with a USD$4 million investment.
  • Sol Global made its first investment in the psychedelic sector, investing $2.6 million into Wesana Health.
  • The company structured and led recent financing into Green Scientific Labs, investing approximately $2.84 million for a 14.5% interest. The Company intends to increase its ownership in GSL by investing further into its RTO financing round, which is imminent.
  • Sol Global made its first green tech investment in the electric motorcycle company Damon Motorcycles. Damon recently raised $30 million after completing a bridge financing round led by SOL Global, Benevolent Capital Partners, LLC, Zirmania Investments Limited, and other investors. SOL Global invested CAD$6.1 million into Damon.

Debra BorchardtFebruary 16, 2021


Verano Holdings Corp. (CSE: VRNO) is set to begin trading on February 17 after closing the reverse takeover of Majesta Minerals Inc. and the merger with Alternative Medical Enterprises LLC, Plants of Ruskin GPS, LLC, RVC 360, LLC, and affiliated companies better known as AltMed and sometimes referred to as AME. The company noted that the Subordinate Voting Shares would begin trading on the CSE, but that the Proportionate Voting Shares will not be listed for trading. 

“Our public listing will provide us access to capital to execute our long-term strategy of expanding into limited-license, high-growth markets and scaling our wholesale and retail operations into new and existing markets,” said CEO George Archos. Archos holds 19.62% of the issued and outstanding SV Shares of Verano. While the subscription price is $10, it is expected that the stock will trade above that level. 

Verano is in 12 U.S. States, with active operations in nine, which includes 23 active retail locations and approximately 440,000 square feet across its six cultivation facilities. Verano produces a full suite of premium, artisanal cannabis products sold under its trusted portfolio of consumer brands: Encore, Avexia, and Verano. Verano designs, builds, and operates inimitable Zen Leaf branded dispensary environments that deliver a superior cannabis shopping experience in both medical and adult-use markets. 

The merger with Alt-Med brings the company the MÜV brand of medical cannabis-infused products which were launched in Arizona in 2016. Alt Med has  29 active retail locations, the AME Parties have 220,000 square feet of cultivation facilities in Florida, and 33,542 square feet in Arizona, which is expected to increase by an additional 110,000 square feet to meet increased demand. 

“The combination with AltMed joins two complementary companies focused on providing superior customer experiences. We have both been disciplined operators since inception, and together we anticipate continuing to generate strong profitability and an EBITDA margin that would rank us near the top of our peer group,” said Mr. Archos. “Our public listing will provide us with access to capital to execute our growth plan, including the organic growth of our retail presence and product portfolio in addition to the pursuit of strategic acquisitions, with the goal of being a top three operator in the states in which we operate.”


For the nine months ending in September 2020, Verano reported revenue of $154 million and AME reported $87 million. The net income for the same period was $118 million for Verano and $88 million for AME. On a pro forma consolidated basis, the nine months of revenue would be $241 million and the net income would be $172 million. 

Winners & Losers

In 2019, Harvest Health & Recreation (OTC: HRVSF) intended to acquire Verano for roughly $850 million. The two companies agreed to terminate the deal without incurring any breakup fees. Part of the problem with the all-stock deal was that Harvest Health’s stock plunged from C$8.79 at the time of the announcement to roughly C$1.62. The stock was lately selling at C$4.61. “This decision was not taken lightly,” said George Archos, Verano Holdings CEO. “While both organizations worked very hard to consummate this transaction, significant delays in closing started with the Hart-Scott-Rodino antitrust review process. Those were followed by state and local regulatory complexities in multiple states.” Harvest has a current market cap of $1.8 billion while Verano’s market cap is expected to be $2.8 billion. 

SOL Global Investments Corp.  (OTCPK: SOLCF) stands to benefit greatly from its investment in Verano. Once the stock begins trading, SOL Global expects to hold 25.2 million subordinate voting shares and was pleased to note that Verano has “effectively scaled up its operations in several key cannabis markets in the U.S., including Illinois, New Jersey and Nevada (either directly or via affiliates/subsidiaries), and is well positioned to continue to generate impressive quarter over quarter growth.”

Sol Global said in a statement that the transaction will have a significant positive impact on its net asset value and the company will update the market in a timely manner as information is available. Sol Global also had to set the record straight with one of its lenders regarding the Verano stake. On February 7, 2021, the company initiated litigation in the State of New York against its lender, 1235 Fund LP, an affiliate of MMCAP who wants Verano stock instead of being paid in cash. 

Back in 2019, the company announced that it had completed a $50,000,000 private placement financing by way of the issue and sale of a senior secured non-convertible debenture. If the deal between Verano and Harvest Health had occurred, the lender would have been repaid in shares of either Verano or Harvest, which would have enabled the lender to cover its short position in Harvest and provided the lender with a reasonable premium of return beyond the stipulated 6%. 

“The Harvest Transaction did not close and thus the Debenture is repayable only in cash. Nevertheless, on February 5, 2021, the lender has wrongfully sent a formal notice purportedly electing to receive, instead of cash, Verano shares currently owned by the Company whose value is more than 200% of the principal value of the Debenture. The Company advised the lender that it will repay the Debenture in cash pursuant to its terms. To address any uncertainty resulting from the lender’s positions, the Company commenced litigation against the lender and another seeking declaratory relief that, among other things, the lender has no right to be repaid in Verano shares. As a result of the lender’s positions, SOL Global has decided that it will no longer do business with it nor participate in any transaction in which the lender is involved.”

Debra BorchardtFebruary 20, 2020


SOL Global Investments Corp. (CSE: SOL) (OTCPK: SOLCF) portfolio company CannCure Investments has entered into a definitive business combination agreement with Goldstream Minerals Inc.  The deal was previously announced in January and the companies are planning a reverse takeover of Goldstream by CannCure.

According to the company statement, the resulting company will initially operate in the State of Florida via One Plant Florida (formerly 3 Boys Farm LLC) and in the event that its proposed acquisition of ECD Holdings Inc. (d/b/a as “Northern Emeralds”) is completed, will begin operations in the State of California. As the company previously announced, Brady Cobb will step down as CEO and a director of SOL Global to lead the new MSO effective upon the closing of the Proposed Transaction. Closing of the Proposed Transaction is expected to occur in late April 2020 or such other date as may be mutually agreed to by the parties.

Goldstream will de-list from the NEX board of the TSX Venture Exchange and the resulting issuer will apply to list its common shares on the Canadian Securities Exchange (CSE). The proposed deal cannot be completed while Goldstream is listed on the NEX board of the TSXV. Sol Global said that an application will be made to voluntarily delist its common shares from the NEX board of the TSXV and to list the common shares of the resulting company on the CSE.

Terms Of The Deal

The company said in the statement that the following terms were part of the deal:

  • the consolidation of Goldstream’s common shares on a 23.3053:1 basis, the issuance of post-Consolidation Goldstream common shares to holders of CannCure common shares on a 1:1 basis;
  • the continuance of Goldstream into the province of British Columbia;
  • the entering into of lock-up agreements by certain CannCure shareholders, officers and directors;
  • CannCure obtaining a US$15,000,000 construction loan from an arm’s length third party lender or completing an alternative financing to ensure sufficient funding for the MSO operations following closing;
  • the approvals of all regulatory bodies having jurisdiction in connection with the Proposed Transaction, including, without limitation, approval from the Florida Department of Health, Office of Medical Marijuana Use; and
  • other closing conditions customary to transactions of the nature of the Proposed Transaction.

StaffJanuary 9, 2020


SOL Global Investments Corp.’s  (CSE: SOL) (OTCPK: SOLCF) CannCure Investments Inc. will be going public through a reverse merger with  Goldstream Minerals Inc. (NEX: GSX.H). The companies entered into a letter of intent dated January 8, 2020, outlining the proposed terms and conditions.  Goldstream will buy a 100% interest in CannCure and then do a reverse takeover by the shareholders of CannCure. The deal is expected to close on or near March 31, 2020.

CannCure will be called “Bluma Wellness Inc.” with operations in Florida via One Plant Florida which is also known as 3 Boys Farm and in California with premium flower cultivator Northern Emeralds. The company said that the LOI was negotiated at arm’s length.

“Bluma will continue to execute on its plan to cultivate and deliver to patients and consumers the highest quality cannabis flower and flower derived products in the coveted Florida marketplace via One Plant Florida, and in California with premium flower producer Northern Emeralds. Bluma will also remain laser-focused on the responsible scale-up of its operations in both Florida and California with a continued focus on its proprietary home delivery model paired with strategically located flagship stores (that will also serve as delivery hubs) and efficient and data-driven premium flower cultivation”, said SOL Global CEO Brady Cobb.

Cobb, who is currently the CEO of SOL Global, will move over to become the CEO and Chairman of Bluma Wellness. SOL Global also stated that it will be the largest shareholder of Bluma. Former CannCure shareholders will become Bluma Shareholders.

“It has been an honor to lead one of the most dynamic and forward-thinking cannabis investment companies, and it’s has been my distinct privilege to work alongside our dedicated team as we assembled an amazing portfolio of cannabis, CBD and Esports investments” continued Brady Cobb. “My strengths have always been on the operations side, and I’m thrilled at the prospect of being able to focus exclusively on scaling up our operations in Florida and California and delivering value to our shareholders.”

Goldstream is listed on the NEX board of the TSX Venture Exchange, the company plans to delist the Goldstream shares from the NEX and then move to the Canadian Stock Exchange. SOL Global will stay at the CSE and the company said that it will not change its business to “that of a life sciences issuer operating as a multi-state cannabis operator in the United States.”


In addition to the reverse takeover announcement, SOL Global also reported that Canadian firm Duff & Phelps completed a valuation of its portfolio of private and public investments and concluded that the value of the Investment Portfolio, as at November 30, 2019, was in a range between $165.2 and $182.4 million with a midpoint of $173.8 million.

The company said that it has 54,459,256 common shares issued and outstanding and the valuation implied an NAV per share of approximately $1.70. The stock was lately trading at 40 cents per share with a market cap of $19 million as per Yahoo! Finance.

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.